Employees Retirement System of Texas’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-5,432
Closed -$79K – 512
2025
Q3
$79K Hold
5,432
– – ﹤0.01% 417
2025
Q2
$61K Hold
5,432
– – ﹤0.01% 467
2025
Q1
$31K Hold
5,432
– – ﹤0.01% 264
2024
Q4
$53K Hold
5,432
– – ﹤0.01% 308
2024
Q3
$44K Hold
5,432
– – ﹤0.01% 332
2024
Q2
$73K Hold
5,432
– – ﹤0.01% 307
2024
Q1
$252K Buy
5,432
+2,675
+97% +$138K ﹤0.01% 307
2023
Q4
$186K Buy
+2,757
New +$169K ﹤0.01% 324

Other funds holding DNA

Employees Retirement System of Texas's DNA Position: Q4 2025 in Review

Employees Retirement System of Texas sold out of Ginkgo Bioworks (DNA) in Q4 2025, closing a stake of 5,432 shares — an estimated $79K sold.

Employees Retirement System of Texas first reported a position in DNA in Q4 2023 and held it in 8 quarters. The position peaked at $252K in Q1 2024. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Employees Retirement System of Texas reported no remaining Ginkgo Bioworks position as of Q4 2025 after selling out during the quarter.
  • Employees Retirement System of Texas sold 5,432 Ginkgo Bioworks shares in Q4 2025, an estimated $79K.
  • Employees Retirement System of Texas first reported a position in Ginkgo Bioworks in Q4 2023 and held it in 8 quarters.
  • Employees Retirement System of Texas's Ginkgo Bioworks position peaked at $252K in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Employees Retirement System of Texas's 13F filing for Q4 2025, filed 9 Feb 2026.